Nextrials Nominated for the World Technology Awards.

Nextrials lauded for its work with industry standards organizations to advance integration of clinical trial data collection platforms with electronic health records

SAN RAMON, Calif. -- Nextrials, Inc. (www.nextrials.com), a leader in clinical research software and services, today announced that it is a nominee in the World Technology Network's 2009 World Technology Awards. Since 2000, this award has been presented annually to outstanding science and technology innovators producing work likely to have the greatest long-term significance. Nextrials was singled out for its recent progress toward integrating Prism[R], its electronic data capture and clinical trial management platform, with platforms used to manage electronic health records in the healthcare setting.

"On average, it costs over $1 billion to develop a new drug, and up to 12 years to complete the clinical trials process, obtain approvals and deliver the drug to market; as it stands, it is a virtually unsustainable system," noted James Rogers, co-founder and CEO of Nextrials. "The biopharmaceutical industry has made great strides in eliminating manual, paper-based systems to help alleviate development costs by using electronic data capture and management platforms such as Prism. Now, by achieving the integration of these platforms with those used to maintain electronic patient records, we can revitalize the market through even more savings in labor, cost and time."

Nextrials was nominated for its contribution to the industry, specifically through participation with industry organizations, such as the Clinical Data Interchange Standards Consortium (CDISC) and Integrating the Healthcare Enterprise (IHE), in developing and implementing EDC and EHR integration standards.

"The World Technology Awards program is a very inspiring way to identify and honor the most innovative organizations in the technology world," said James P. Clark, founder and Chairman of the World Technology Network. "Nextrials' forward-thinking approach will undoubtedly hold long-term significance to both the pharmaceutical and healthcare industries."

Nextrials' award-winning Prism melds sophisticated clinical trial management functionality with electronic data capture in a single, integrated package. It is currently used worldwide by biopharmaceutical and medical device R&D teams developing novel treatments and therapeutics. Visitors to the 18th Annual Partnerships with CROs Conference, being held April 28-30 at the Rosen Shingle Creek Hotel in Orlando, FL, can view a demonstration of Prism in Nextrials' booth #601.

About The World Technology Network

The World Technology Network is a New York-headquartered organization that was created to "encourage serendipity" - happy accidents - amongst those individuals and companies deemed by their peers to be the most innovative in the science and technology world. The WTN's areas of interest range from IT and communications to biotech, energy, materials, space, as well as related fields such as finance, marketing, policy, law, design, and ethics. For more information, visit http://www.wtn.net/.

About Nextrials

Founded by pharmaceutical researchers in 1999, Nextrials offers today's most novel products and services for speeding the delivery of life-saving drugs and medical devices to market. Prism([R]), its award-winning Electronic Data Capture (EDC) solution, has been used at over 1,000 research sites to streamline the initiation and management of clinical trials. The company is headquartered in the San Francisco Bay area. For more information, visit www.nextrials.com, follow us on Twitter @Nextrials, or call 925-355-3000. A podcast by co-founder and CEO James Rogers on the incorporation of electronic health records into the clinical trial process is also available at http://pharmavoice.com/podcasts.